Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Explore affordable index funds for retirement and learn how low fees can boost your long-term gains. This intro covers selection basics and cost considerations.
23,808 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
SpaceX isn’t just about rockets. This investing guide shows how spacex could become most AI company by turning data, ...
Nvidia is fueling a bold thesis for H2 2026 as AI infrastructure demand climbs. With data-center momentum and locked-...
Micron’s stock sprinted higher on AI-driven demand, prompting a strategist to flag a potential entry on a pullback. T...
JPMORGAN Global Research says the AI-related capital spend is not a fleeting hype cycle but a profitable buildout. Th...
Palantir rides a wave of AI-driven demand as shares hover around $113. A fresh forecast calls for meaningful upside o...
A bold forecast from Google Gemini AI points to a dramatic Micron price move by year-end 2026. Analysts say the model...
Snap co-founder Evan Spiegel and Miranda Kerr are funding a California medical debt relief program, potentially wipin...
Grandparents are increasingly using a dividend-focused plan to fund college costs, aiming to preserve principal while...
Travelers are receiving emails that imitate real reservations, complete with names, dates, and confirmation numbers. ...
What happens when AI breakthroughs and high-flying tech bets collide with political markets? This article explains th...
SpaceX's Starlink program could redefine internet access and investor value. This year’s launch pace hinges on regula...